The largest database of trusted experimental protocols

9 protocols using beh phenyl column

1

Quantification of 1,25D by LC-MS/MS and Chemiluminescence

Check if the same lab product or an alternative is used in the 5 most similar protocols
1,25D was measured using a chemiluminescent assay or LC–MS. LIASON XL chemiluminescent assay was performed by Dr. Claudia Zierold (detection limit 5 pg/mL, DiaSorin, Stillwater, MN, USA) (28 (link)). For measurement by LC–MS, 1,25D was first concentrated according to kit instructions (Immundiagnostick, Bensheim, Germany) and measured as described earlier using authentic standards (d3-1,25D3 and 1,25D3, Isosciences) 1,25D samples (10 µL) were separated as described earlier with a Waters (Milford, MA, USA) BEH Phenyl column (150 mm × 1.0 mm 1.7 μm particle size) and a flow rate of 90 µL/min. The eluate was delivered either into a 5600 QTOF or a 6500 QTRAP as described earlier, with two 100 ms MS/MS product ion scans (m/z 762.5 and 765.5) from 50 to 950 per duty cycle using a collision energy of 37 V. For the QTRAP the capillary voltage was 5.5 kV in positive ion mode with a declustering potential of 80 V and the collision energy was 38 V. LC–MS/MS using the QTRAP was performed by Dr. Rahul Baghla (detection limit 4 pg/mL, Sciex, Redwood City, CA, USA). Chromatograms, ion spectra, structure, and fragmentation of DMEQ-TAD 4-[2-(6,7-dimethoxy-4-methyl-3,4-dihydroquinoxalinyl)ethyl]-1,2,4-triazoline-3,5-dione (DMEQ-TAD) adducts of vitamin D, 25D, 24,25D, and 1,25D examples are shown in Figure S1 in Supplementary Material (27 (link)).
+ Open protocol
+ Expand
2

Quantification of Bile Acids by HPLC-RI

Check if the same lab product or an alternative is used in the 5 most similar protocols
Concentrations of CA and related substances (CDCA, DCA, MCA, or unidentified) were determined using a high-performance liquid chromatography system with refractive index (HPLC-RI) detection using RID-10A from Shimadzu. A reversed phase X-bridge BEH phenyl column measuring 250 × 4.6 × 3.5 μm (Waters Corporation) was used. Column temperature was kept at 30 °C ± 2 °C. All samples were dissolved and diluted in methanol and subsequently analyzed. The reference and sample solutions were tested to be stable for 7 days at room temperature (15–25 °C) and in the refrigerator (2–8 °C). The mobile phase consisted of 30 mmol/L potassium dihydrogen phosphate (KH2PO4) and 600 μL phosphoric acid in a 1 L mixture of water/acetonitril (ACN) (60:40). The differential refractometer was maintained at 40 °C. The injection volume was 30 μL. The flow rate was 1.0 mL/min. The chromatograms were obtained with a resolution of ≥1.5. The retention times were ±8.3 min for CA, ±17.8 min for CDCA, and ±21 min for MCA. Chromatograms were processed using Labsolutions software from Shimadzu. The HPLC-RI method was validated according to the Ph.Eur. individual monograph for CDCA [34 ], which described an analytical method similar to what was required and the ICH Q2(R1) guideline regarding accuracy, precision, specificity, detection and quantitation limits, and linearity [35 ].
+ Open protocol
+ Expand
3

Quantification of Tamoxifen and Metabolites in BM Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tamoxifen and seven metabolites (Table 2) were quantified in human BM plasma samples collected ~ 8 months from tamoxifen initiation using our previously described method for serum [17]. In brief, protein precipitation (20 μL) of BM plasma was performed in acetonitrile containing deuterated internal standards. The supernatant (80 μL) was evaporated to dryness using nitrogen and subsequently reconstituted in 500 μL water : methanol (20 : 80, v:v). Subsequently, the samples were chromatographically separated on a Waters Acquity UPLC system (Milford, MA, USA) using a Waters BEH Phenyl column (100 mm × 2.1 mm, 1.7 μm particle size). The column was developed by a gradient elution of 0.01% aqueous solution of formic acid and methanol as weak and strong mobile phases, respectively. The compounds were subjected to atmospheric pressure photoionization and detected in positive ion mode using a Xevo TQ‐S tandem mass spectrometer (Waters, Taunton, MA, USA). All measured concentrations were multiplied by 3 to account for the dilution factor caused by adding 2 volumes of PBS during the isolation of mononuclear cells.
+ Open protocol
+ Expand
4

Quantitative Analysis of Ginseng Saponins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chemical constitutions of PNS and PNE were quantitatively determined using a Waters ACQUITY-UPLC CLASS system (Waters Corp., USA) coupled with an ACQUITY UPLC BEH phenyl column (150 mm × 2.1 mm, 1.7 μm) maintained at 45°C. Elution was performed with a mobile phase of water (A) and Acetonitrile (B) under a gradient program: 0-10 min, 19% B; 10-15 min, 19-35% B; 15-20 min, 35-38% B. The flow rate was 0.4 mL/min, and the injection volume was 2 μL. The analytes were monitored at the UV wavelength of 205 nm. Prior to the next injection, the column was washed with 100% B for 2 min and then equilibrated with the initial mobile phase for 3 min. Notogisenoside R1, ginsenoside Rb1, ginsenoside Re, ginsenoside Rg1, and ginsenoside Rd (the purities of all standards were higher than 98% by HPLC analysis) were purchased from Chengdu Pufei De Biotech Co., Ltd. (China). Acetonitrile was purchased from RCI Labscan Limited (Thailand) of HPLC grade. Milli-Q water was prepared using a Milli-Q system (Millipore, USA).
+ Open protocol
+ Expand
5

UPLC-MS Analysis of Organic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The analysis was carried out with an Acquity UPLC system (Waters, Milford, MA, USA) consisting of an auto-sampler, a binary pump equipped with a 10 µL Loop (partial Loop injection mode) and a BEH PHENYL column (2.1 mm × 100 mm, 1.7 µm; WATERS, Waxford, Ireland). The solvents used were (A) water + 0.1% (v/v) formic acid and (B) acetonitrile + 0.1% (v/v) formic acid at a constant flow rate of 0.3 mL·min1 . The elution gradient (for 113 min) was 100% A, gradually decreasing until reaching 10% A and 90% B, to move from normal conditions (100% A) one minute later to re-equilibrate the column. MS detection was performed on a Q-ToF quadrupole orthogonal acceleration time-of-flight mass spectrometer (Q-TOF™, Waters, Milford, MA, USA) equipped with an electrospray ionization source (ESI). The sample acquisition mode was in negative ionic polarity, analysis mode in sensitivity and normal dynamic range, in a mass range of 50 to 1200 Da, sweep conditions of 0.5 s1 , a centroid data format, a collision energy of 6 V and a cone voltage of 40 V.
+ Open protocol
+ Expand
6

Amino Acid Analysis of Hydrothermal Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten microliters of the 10-fold diluted hydrothermal experimental product of the 150°C experiment and the associated control sample were treated with the same preparation protocol (acid hydrolysis and desalting), as outlined in the previous section. The dried, desalted samples were redissolved in 100 μl of water. Twenty microliters of the samples was derivatized with OPA/NAC fluorescent derivatization immediately before analysis, as previously described (39 ).
The amino acid abundances and distributions were measured by UPLC-FD/QToF-MS at NASA Johnson Space Center (JSC) using a Waters ACQUITY UPLC and a Waters ACQUITY fluorescence detector connected to a Waters Xevo G2-XS QTof. Twenty-five microliters of the derivatized samples was separated using a Waters BEH C18 column (2.1 × 50 mm; 1.7-μm particle size), followed by a second Waters BEH phenyl column (2.1 × 150 mm; 1.7-μm particle size). Chromatographic conditions were as follows: column temperature, 30°C; flow rate, 150 μl/min; solvent A [50 mM ammonium formate and 8% methanol (pH 8.0)]; solvent B (methanol); gradient time (%B): 0 min (0), 35 min (55), and 45 min (100). The electrospray and mass spectrometer conditions have been described in detail by Glavin et al. (39 ). Amino acids were identified by comparison to known standards using the detected masses at the expected chromatographic retention times.
+ Open protocol
+ Expand
7

HPLC-QTOF Analysis of Vitamin D Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples (5μl) were separated by reverse phase HPLC using a Prominence 20 UFLCXR system (Shimadzu, Columbia MD) with a Waters (Milford, MA) BEH Phenyl column (100mm × 2.1mm 1.7 μm particle size). Solvents used were HPLC grade water with 0.1% formic acid and HPLC grade acetonitrile with 0.1% formic acid. The initial conditions were 70% water and 30% acetonitrile, increasing to 50% acetonitrile at 10 min, 90% acetonitrile at 12 min where it was held at 90% acetonitrile until 13 min before returning to the initial conditions. The eluate was delivered into a 5600 (QTOF) TripleTOF using a Duospray™ ion source (AB Sciex, Framingham, MA). The capillary voltage was set at 5.5 kV in positive ion mode with a declustering potential of 80V. The mass spectrometer was operated with a 250 ms TOF scan from 50 to 950 m/z, and 7 100 ms MS/MS product ion scans (m/z 730.5, 733.5, 746.5, 749.5, 762.5, 765.5, 768.5) from 50 to 950 per duty cycle using a collision energy of 45V with a 30V spread. Chromatograms and ion spectra, and structure and fragmentation of DMEQ-TAD adducts of vitamin D, 25D, and 24,25D used for detection, are shown in Supplementary (S)Figure 1.
+ Open protocol
+ Expand
8

HPLC-MS/MS Quantification of MCLR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brown glass vials with polypropylene PTFE vial caps were used to ship reconstituted, undiluted aliquots of MCLR vendor samples to EPA in Las Vegas, Nevada (EPA, NV) for validation of our standards measurements. Samples were shipped from the EPA, NC to the EPA, NV overnight on ice.
The seven MCLR vendor samples were also quantified by HPLC-MS/MS using an Agilent 1290 Infinity II HPLC coupled to an Agilent 6495 Triple Quadrupole MS with positive ESI. The HPLC was equipped with a BEH phenyl column (2.1 × 100 mm, 1.7 μm, Waters Corp, Milford, MA, USA) at 35 °C and mobile phase running at 300 μL/min consisting of (A) 0.05% acetic acid in 95:5 DI water-methanol and (B) 0.05% acetic acid in 95:5 methanol-DI water. All samples received were diluted accordingly such that two concentrations (5 and 50 pg/μL) from each vendor were used for the analysis. A 20-μL diluted sample was injected and eluted with the following gradient: initial condition of 35% B ramped to 90% B over 5 min and held for 1.5 min, then back to initial condition over 3.5 min followed by a 3 min post time equilibration prior to the next run. The MS acquisition was performed in positive polarity using the 2+ precursor ion 498.3 with product ions 135.2, 105.1 and 103.1. An external five-point calibration curve was prepared using NRC Canada CRM and quantified using product ion 135.2 peak area.
+ Open protocol
+ Expand
9

Quantification of Analytes via UPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
An ACQUITY ultra-performance LC system (Waters, Milford, MA, USA) with a BEH phenyl column (2.1×50.0 mm, 1.7 µm) was used, and the test was performed under the following conditions: dose, 20 µL; analysis time, 5 minutes; flow rate, 0.45 mL/min; mobile phase A, 2 mM ammonium acetate with 0.1% formic acid solution (distilled water); and mobile phase B, 2 mM ammonium acetate with 0.1% formic acid (methanol). The ACQUITY TQD was used, and the test was performed under the following conditions: electrospray ionization, positive ion mode, and multiple reaction monitoring. All analyses of the measured data were performed using the QuanLynx 4.0 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!